New vaccines for old diseases: trivalent cold-adapted influenza vaccine

W Paul Glezen1

  • 1Department of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Houston, TX 77030-3498, USA.

Pediatric Annals
|September 10, 2004
PubMed

Insights

School-based influenza vaccination clinics using a single-dose nasal spray vaccine (CAIV-T) can significantly reduce illness in children and protect vulnerable populations. This approach is crucial for intensifying control measures and pandemic preparedness.

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Public health

Background:

  • Schoolchildren experience the highest influenza attack rates.
  • School-based vaccination clinics offer efficient delivery to a large child population.
  • Current influenza vaccine coverage has plateaued, hindering progress toward public health goals.

Purpose of the Study:

  • To demonstrate the field effectiveness of school-based vaccination in reducing influenza transmission.
  • To evaluate the impact of universal childhood immunization as a supplement to existing control strategies.
  • To assess the role of live attenuated influenza vaccine delivered intranasally (CAIV-T) in influenza control and pandemic preparedness.

Main Methods:

  • A field trial in central Texas to demonstrate the impact of school-based vaccination.
  • Modeling studies showing vaccination of 70% of schoolchildren can dampen epidemics.
  • Utilizing CAIV-T for its single-dose effectiveness, ease of administration, and child acceptance.

Main Results:

  • Vaccinating 70% of schoolchildren is predicted to significantly reduce influenza epidemics.
  • School-based CAIV-T offers advantages for high-coverage immunization campaigns.
  • Universal childhood immunization can supplement current influenza control efforts.

Conclusions:

  • School-based CAIV-T can effectively reduce influenza attack rates in children.
  • This strategy can protect vulnerable community members by reducing overall transmission.
  • CAIV-T is a valuable tool for enhancing influenza control and pandemic preparedness.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...